GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » PB Ratio

Vitrolife AB (OSTO:VITR) PB Ratio : 1.79 (As of May. 05, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-05), Vitrolife AB's share price is kr175.20. Vitrolife AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr97.68. Hence, Vitrolife AB's PB Ratio of today is 1.79.

The historical rank and industry rank for Vitrolife AB's PB Ratio or its related term are showing as below:

OSTO:VITR' s PB Ratio Range Over the Past 10 Years
Min: 0.99   Med: 8.61   Max: 26.3
Current: 1.79

During the past 13 years, Vitrolife AB's highest PB Ratio was 26.30. The lowest was 0.99. And the median was 8.61.

OSTO:VITR's PB Ratio is ranked better than
58.96% of 792 companies
in the Medical Devices & Instruments industry
Industry Median: 2.245 vs OSTO:VITR: 1.79

During the past 12 months, Vitrolife AB's average Book Value Per Share Growth Rate was -22.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 71.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 64.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 42.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vitrolife AB was 101.90% per year. The lowest was -4.20% per year. And the median was 18.00% per year.

Back to Basics: PB Ratio


Vitrolife AB PB Ratio Historical Data

The historical data trend for Vitrolife AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB PB Ratio Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.95 11.64 4.95 1.51 2.07

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 1.60 1.14 2.07 2.06

Competitive Comparison of Vitrolife AB's PB Ratio

For the Medical Devices subindustry, Vitrolife AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's PB Ratio falls into.



Vitrolife AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Vitrolife AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=175.20/97.684
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Vitrolife AB  (OSTO:VITR) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Vitrolife AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (OSTO:VITR) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines